Latest news
Sandoz receives FDA approval for Tyruko®(natalizumab-sztn), 预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土预应力混凝土
非vartis builds on neuroscience pipeline and xRNA platform capabilities with acquisition of DTx Pharma
Novartis publishes new five-year efficicacy data on Kesimpta®(ofatumumumab)for the treatment of relapsing multiple sclerosis
我的Love Stories
Fighting MS through innovation
S Shared decision making tools
资源链接
Events and scientific meetings